PROGRAM OVERVIEW

The Association of Black Cardiologists, Inc. (ABC) has a long tradition of sponsoring physician education and has offered updates on topics of interest to health care providers for more than three decades. ABC activities are designed to achieve two primary educationalgoals:

• Provide a forum for thought leaders in Cardiovascular Medicine to build awarenessof health disparities in cardiovascular risk management for people of color; and
• Challenge the target audiences with applying a mix of data, current practical perspective from expert thought leaders and translation of therapeutic guidelines, to the management of cardiovascular patients.

Today, cardiovascular disease remains the leading cause of death in the U.S. and a recurrent cause of morbidity. Because of its complex nature, there is an ongoing need to discuss the current status and future direction of cardiovascular medicine and surgery.

This year’s program, Changing Paradigms in Major Aspect of Cardiovascular Care, will provide an update of new and developing therapies, technologies, research, guidelines and other concepts in response to frequent questions from cardiologists, primary care physicians and other health care providers. Topics have been selected to expand knowledge and to offer strategies to assist clinicians in the management of cardiovascular disease, including ß-blocker therapy and clinical outcomes, new and emerging advances in lipid lowering, new perspectives on glycemic management, cardiomyopathies and heart failure, and resource utilization in cardiovascular care.

PROGRAM CO-CHAIRS

Ola O. Akinboboye, MD, MPH, MBA, FACC
Associate Professor of Clinical Medicine
Cornell University-New York
Associate Director
Division of Cardiology
Director of Cardiac Imaging
New York Hospital Queens

Judith E. Mitchell, MD, FACC
Associate Professor of Medicine
Director of the Heart Failure Center
State University of New York Health
Center-Brooklyn

LEARNING OBJECTIVES

Upon completion of this educational program, participants should be better able to:

• Differentiate between the various ß-blockers in terms of efficacy, safety, side effect profile and mechanism of action in patients with hypertension
  
• Review evidence for use of beta blockers in reducing perioperative cardiac risk
  
• Review current guidelines supporting treatment and management recommendations for valve disease
  
• Assess glycemic control and CV risk in patients with type 2 diabetes; describe the role of HDL in reducing cardiovascular disease
  
• Discuss the interplay between race/ethnicity, inflammation and lipids
  
• Review potential implications of clinical research for prevention guidelines
  
• Demonstrate familiarity with the evaluation and treatment of patients with cardiomyopathies and heart failure
  
• Describe practical strategies to prevent or minimize cardiovascular risk factors in HIV-infected patients
  
• Describe the applications of cardiac MR and CT imaging in the diagnosis and management of unusual cardiomyopathies
  
• Examine resource utilization in cardiovascular care from clinical and payor perspectives

TARGET AUDIENCE

This program is intended for cardiologists, cardiothoracic surgeons, nephrologists, neurologists, internists, primary care physicians, physician assistants, nurses and other health professionals
who treat patients with or at risk for cardiovascular diseases.

FACULTY DISCLOSURE

The Association of Black Cardiologists adheres to the ACCME Essential Areas, Standards and Policies regarding industry support of continuing medical education. Disclosure of faculty and commercial relationships will be made known at the activity. Speakers are required to openly disclose any limitations of data and/or any discussion of any off-label, experimental, or investigational uses of drugs or devices in their presentations.

ACCREDITATION

The Association of Black Cardiologists, Inc. (ABC) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The ABC designates this educational activity for a maximum of 6.5 AMA PRA Category 1 Credits ™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

SPECIAL NEEDS

The ABC is committed to making its activities accessible to all individuals. If you are in need of an accommodation, please do not hesitate to call and/or submit a description of your needs in writing in order to receive service.

RESOLUTION OF CONFLICTS OF INTEREST

In accordance with the ACCME Standards for Commercial Support of CME, the Association of Black Cardiologists will implement mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

SUPPORTERS

This program is supported, in part, by educational grants from AstraZeneca, Fold Rx, Medtronic, Merck and Merck/Schering-Plough.



This event is not part of the official ACC Annual Scientific Session and/or the American College of Cardiology’s Innovation in Intervention: i2 Summit in Partnership with the Cardiovascular Research Foundation (CRF) as planned by their Program Committees.